
Tissue engineering scaffolds are three-dimensional structures designed to support and guide cell growth for tissue repair and regeneration.
The global Tissue Engineering Scaffolds market size is projected to grow from US$ 329 million in 2024 to US$ 587 million in 2030; it is expected to grow at a CAGR of 10.1% from 2024 to 2030.
LPI (publisher)' newest research report, the “Tissue Engineering Scaffolds Industry Forecast” looks at past sales and reviews total world Tissue Engineering Scaffolds sales in 2022, providing a comprehensive analysis by region and market sector of projected Tissue Engineering Scaffolds sales for 2023 through 2029. With Tissue Engineering Scaffolds sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tissue Engineering Scaffolds industry.
This Insight Report provides a comprehensive analysis of the global Tissue Engineering Scaffolds landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tissue Engineering Scaffolds portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tissue Engineering Scaffolds market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tissue Engineering Scaffolds and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tissue Engineering Scaffolds.
Global core manufacturers of scaffold-based 3D Cell Culture Scaffold include Thermo Fisher Scientific, Corning, Merck, Greiner Bio-One, Lonza Group and Reprocell Incorporated.
In terms of product type, Animal Origin-Free Bioscaffolds occupy a dominant position, accounting for 93% of the market share. At the same time, in terms of applications, Efficacy vs. Toxicology Testing is the largest application areas, accounting for 97%.
This report presents a comprehensive overview, market shares, and growth opportunities of Tissue Engineering Scaffolds market by product type, application, key players and key regions and countries.
Segmentation by Type:
Animal Origin Bioscaffold
Animal Origin-Free Bioscaffold
Segmentation by Application:
3D Cell Culture
Cellular Agriculture
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Animal Origin Bioscaffold
Animal Origin-Free Bioscaffold
Segmentation by Application:
3D Cell Culture
Cellular Agriculture
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Corning
Merck
Greiner Bio-One
Lonza Group
Reprocell Incorporated
Jet Bio-Filtration
InSphero AG
3D Biotek
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tissue Engineering Scaffolds Market Size 2019-2030
2.1.2 Tissue Engineering Scaffolds Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Tissue Engineering Scaffolds by Country/Region, 2019, 2023 & 2030
2.2 Tissue Engineering Scaffolds Segment by Type
2.2.1 Animal Origin Bioscaffold
2.2.2 Animal Origin-Free Bioscaffold
2.3 Tissue Engineering Scaffolds Market Size by Type
2.3.1 Tissue Engineering Scaffolds Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tissue Engineering Scaffolds Market Size Market Share by Type (2019-2024)
2.4 Tissue Engineering Scaffolds Segment by Application
2.4.1 3D Cell Culture
2.4.2 Cellular Agriculture
2.5 Tissue Engineering Scaffolds Market Size by Application
2.5.1 Tissue Engineering Scaffolds Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tissue Engineering Scaffolds Market Size Market Share by Application (2019-2024)
3 Tissue Engineering Scaffolds Market Size by Player
3.1 Tissue Engineering Scaffolds Market Size Market Share by Player
3.1.1 Global Tissue Engineering Scaffolds Revenue by Player (2019-2024)
3.1.2 Global Tissue Engineering Scaffolds Revenue Market Share by Player (2019-2024)
3.2 Global Tissue Engineering Scaffolds Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Tissue Engineering Scaffolds by Region
4.1 Tissue Engineering Scaffolds Market Size by Region (2019-2024)
4.2 Global Tissue Engineering Scaffolds Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tissue Engineering Scaffolds Market Size Growth (2019-2024)
4.4 APAC Tissue Engineering Scaffolds Market Size Growth (2019-2024)
4.5 Europe Tissue Engineering Scaffolds Market Size Growth (2019-2024)
4.6 Middle East & Africa Tissue Engineering Scaffolds Market Size Growth (2019-2024)
5 Americas
5.1 Americas Tissue Engineering Scaffolds Market Size by Country (2019-2024)
5.2 Americas Tissue Engineering Scaffolds Market Size by Type (2019-2024)
5.3 Americas Tissue Engineering Scaffolds Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tissue Engineering Scaffolds Market Size by Region (2019-2024)
6.2 APAC Tissue Engineering Scaffolds Market Size by Type (2019-2024)
6.3 APAC Tissue Engineering Scaffolds Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Tissue Engineering Scaffolds Market Size by Country (2019-2024)
7.2 Europe Tissue Engineering Scaffolds Market Size by Type (2019-2024)
7.3 Europe Tissue Engineering Scaffolds Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tissue Engineering Scaffolds by Region (2019-2024)
8.2 Middle East & Africa Tissue Engineering Scaffolds Market Size by Type (2019-2024)
8.3 Middle East & Africa Tissue Engineering Scaffolds Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Tissue Engineering Scaffolds Market Forecast
10.1 Global Tissue Engineering Scaffolds Forecast by Region (2025-2030)
10.1.1 Global Tissue Engineering Scaffolds Forecast by Region (2025-2030)
10.1.2 Americas Tissue Engineering Scaffolds Forecast
10.1.3 APAC Tissue Engineering Scaffolds Forecast
10.1.4 Europe Tissue Engineering Scaffolds Forecast
10.1.5 Middle East & Africa Tissue Engineering Scaffolds Forecast
10.2 Americas Tissue Engineering Scaffolds Forecast by Country (2025-2030)
10.2.1 United States Market Tissue Engineering Scaffolds Forecast
10.2.2 Canada Market Tissue Engineering Scaffolds Forecast
10.2.3 Mexico Market Tissue Engineering Scaffolds Forecast
10.2.4 Brazil Market Tissue Engineering Scaffolds Forecast
10.3 APAC Tissue Engineering Scaffolds Forecast by Region (2025-2030)
10.3.1 China Tissue Engineering Scaffolds Market Forecast
10.3.2 Japan Market Tissue Engineering Scaffolds Forecast
10.3.3 Korea Market Tissue Engineering Scaffolds Forecast
10.3.4 Southeast Asia Market Tissue Engineering Scaffolds Forecast
10.3.5 India Market Tissue Engineering Scaffolds Forecast
10.3.6 Australia Market Tissue Engineering Scaffolds Forecast
10.4 Europe Tissue Engineering Scaffolds Forecast by Country (2025-2030)
10.4.1 Germany Market Tissue Engineering Scaffolds Forecast
10.4.2 France Market Tissue Engineering Scaffolds Forecast
10.4.3 UK Market Tissue Engineering Scaffolds Forecast
10.4.4 Italy Market Tissue Engineering Scaffolds Forecast
10.4.5 Russia Market Tissue Engineering Scaffolds Forecast
10.5 Middle East & Africa Tissue Engineering Scaffolds Forecast by Region (2025-2030)
10.5.1 Egypt Market Tissue Engineering Scaffolds Forecast
10.5.2 South Africa Market Tissue Engineering Scaffolds Forecast
10.5.3 Israel Market Tissue Engineering Scaffolds Forecast
10.5.4 Turkey Market Tissue Engineering Scaffolds Forecast
10.6 Global Tissue Engineering Scaffolds Forecast by Type (2025-2030)
10.7 Global Tissue Engineering Scaffolds Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Tissue Engineering Scaffolds Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Tissue Engineering Scaffolds Product Offered
11.1.3 Thermo Fisher Scientific Tissue Engineering Scaffolds Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Corning
11.2.1 Corning Company Information
11.2.2 Corning Tissue Engineering Scaffolds Product Offered
11.2.3 Corning Tissue Engineering Scaffolds Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Corning Main Business Overview
11.2.5 Corning Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Tissue Engineering Scaffolds Product Offered
11.3.3 Merck Tissue Engineering Scaffolds Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 Greiner Bio-One
11.4.1 Greiner Bio-One Company Information
11.4.2 Greiner Bio-One Tissue Engineering Scaffolds Product Offered
11.4.3 Greiner Bio-One Tissue Engineering Scaffolds Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Greiner Bio-One Main Business Overview
11.4.5 Greiner Bio-One Latest Developments
11.5 Lonza Group
11.5.1 Lonza Group Company Information
11.5.2 Lonza Group Tissue Engineering Scaffolds Product Offered
11.5.3 Lonza Group Tissue Engineering Scaffolds Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lonza Group Main Business Overview
11.5.5 Lonza Group Latest Developments
11.6 Reprocell Incorporated
11.6.1 Reprocell Incorporated Company Information
11.6.2 Reprocell Incorporated Tissue Engineering Scaffolds Product Offered
11.6.3 Reprocell Incorporated Tissue Engineering Scaffolds Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Reprocell Incorporated Main Business Overview
11.6.5 Reprocell Incorporated Latest Developments
11.7 Jet Bio-Filtration
11.7.1 Jet Bio-Filtration Company Information
11.7.2 Jet Bio-Filtration Tissue Engineering Scaffolds Product Offered
11.7.3 Jet Bio-Filtration Tissue Engineering Scaffolds Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Jet Bio-Filtration Main Business Overview
11.7.5 Jet Bio-Filtration Latest Developments
11.8 InSphero AG
11.8.1 InSphero AG Company Information
11.8.2 InSphero AG Tissue Engineering Scaffolds Product Offered
11.8.3 InSphero AG Tissue Engineering Scaffolds Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 InSphero AG Main Business Overview
11.8.5 InSphero AG Latest Developments
11.9 3D Biotek
11.9.1 3D Biotek Company Information
11.9.2 3D Biotek Tissue Engineering Scaffolds Product Offered
11.9.3 3D Biotek Tissue Engineering Scaffolds Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 3D Biotek Main Business Overview
11.9.5 3D Biotek Latest Developments
12 Research Findings and Conclusion
*If Applicable.
